9dbn
Tarantula venom peptide Protoxin-I bound to full-length human voltage-gated sodium channel 1.8 (NaV1.8)
Structural highlights
FunctionTXPR1_THRPR Inhibits voltage-gated calcium channels Cav3.1/CACNA1G, voltage-gated potassium channels Kv2.1/KCNB1 and all sodium channels tested (Nav1.2/SCN2A, Nav1.5/SCN5A, Nav1.7/SCN9A, and Nav1.8/SCN10A). Shifts the voltage-dependence of channel activation to more positive potentials. Most potent against Nav1.8/SCN10A.[1] [2] Publication Abstract from PubMedVoltage-gated sodium channels (Na(V)s) selectively permit diffusion of sodium ions across the cell membrane and, in excitable cells, are responsible for propagating action potentials. One of the nine human Na(V) isoforms, Na(V)1.8, is a promising target for analgesics, and selective inhibitors are of interest as therapeutics. One such inhibitor, the gating-modifier peptide Protoxin-I derived from tarantula venom, blocks channel opening by shifting the activation voltage threshold to more depolarized potentials, but the structural basis for this inhibition has not previously been determined. Using monolayer graphene grids, we report the cryogenic electron microscopy structures of full-length human apo-Na(V)1.8 and the Protoxin-I-bound complex at 3.1 A and 2.8 A resolution, respectively. The apo structure shows an unexpected movement of the Domain I S4-S5 helix, and VSD(I) was unresolvable. We find that Protoxin-I binds to and displaces the VSD(II) S3-S4 linker, hindering translocation of the S4(II) helix during activation. Structural basis of inhibition of human Na(V)1.8 by the tarantula venom peptide Protoxin-I.,Neumann B, McCarthy S, Gonen S Nat Commun. 2025 Feb 7;16(1):1459. doi: 10.1038/s41467-024-55764-z. PMID:39920100[3] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
| ||||||||||||||||||||
